openPR Logo
Press release

Current Technological Advancements on Erythropoietin Drugs Market SWOT Analysis & Technological Innovation by Leading Industry Experts

06-20-2019 08:27 PM CET | Health & Medicine

Press release from: Allied Market Research

Erythropoietin Drugs Market

Erythropoietin Drugs Market

"Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020", forecasts the Global EPO market to reach $11.9 billion by 2020, with promising CAGR of 9.7% from 2014 to 2020. Darbepoetin alfa is fastest growing drug class at a CAGR of 12.9% during the forecast period, owing to its high potency and minimal side-effects.

Download the Sample Report @

Rising incidences of Cancer, ESRD (End Stage Renal Disease), and HIV have largely contributed to the overwhelming demand for EPO drugs. Approximately 20% of the patients suffering from Cancer/HIV and ~70% of the patients suffering from ESRD undergo chemotherapy, which induces anemia in such patients, requiring EPO treatment. Despite this, the market nevertheless witnesses restraints due to highly priced EPO drugs resulting in minimal adoption. However, commercialization of EPO biosimilars would eventually ease the influence of restraints and fuel the market growth, primarily across the developing regions.

Globally, ~70% of the market share is held by the developed regions owing to favorable reimbursements leading to affordability for EPO drugs. Going forward, owing to commercialization of EPO biosimilars, the Asia-Pacific EPO drugs market would be the most potential market among other regions.

Key findings of the study:
• Europe led the global EPO drug market in 2013 closely followed by North America
• Asia Pacific EPO drugs market is projected to grow at a CAGR of 13.3% during the forecast period, fastest among the four geographies
• Currently, Anemia therapeutics (Cancer and HIV treatment) market leads the overall EPO drugs market; however, kidney therapeutic segment would emerge as the largest market segment by 2020
• Originator companies are investing in R&D for expanding product i.e. EPO drug applications to newer disorders such as neural diseases and in wound healing
• EPO drugs market is witnessing high commercialization of biosimilars for the 'off-patent' drug namely Erythropoietin alfa

For More Inquiry @

The first EPO drug - Epogen (Erythropoietin alfa), launched by Amgen, has witnessed patent expiry in 2014. Following this, a number of biosimilar Erythropoietin alfa have been launched by major companies such as Biocon, Ranbaxy, Emcure Pharmaceuticals. In addition, Amgen currently owns the patent Aranesp for Darbepoetin alfa; which is expected to expire by 2016, thus, calling for launch of Darbepoetin alfa biosimilars.

Some of leading players operating in EPO drug market are Amgen Inc., Johnson & Johnson, Roche, LG Life Sciences Ltd., Biocon, Intas Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Celltrion, Inc.

Contact Us:-
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

About Us:-
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Current Technological Advancements on Erythropoietin Drugs Market SWOT Analysis & Technological Innovation by Leading Industry Experts here

News-ID: 1783093 • Views: 341

More Releases from Allied Market Research

Safety Relay Market Growth Projections and Performance Forecast Analysis for the …
Allied Market Research published a new report, titled, "Safety Relay Market by Type (Single-Function Safety Relays and Modular & Configurable Safety Relays), Contact (Normally Closed, Time Open (NCTO), Normally Closed, Time Closed (NCTC), Normally Open, Time Open (NOTO), Normally Open, Time Closed (NOTC)) and End User (Automotive, Energy & Power, Manufacturing, Pharmaceutical, Construction, Semiconductors, and Oil & Gas): Global Opportunity Analysis and Industry Forecast, 2020–2026." The research report offers an in-depth
Investment Opportunity: Global Servo Drive Market Growing at Alarming Growth Rat …
Allied Market Research published a new report, titled, "Servo Drive Market By Type (Torque Servo, Velocity Servo, and Positioning Servo), Motor Power (Up to 1 kW, 1-2 kW, 2-5 kW, 5-15 kW, and >15 kW), Electrical Drives (DC Drive and AC Drive), Machinery (Small Equipment, Medium Machinery, and Large Machinery), and End Application (Commercial & Other Industry, Aerospace & Other Transportation Equipment, Household Appliances, Industrial Machinery, Heating Ventilating & Cooling
Thyristor Market Growth Projections and Competitive Scenario 2020-2026 | Major P …
Allied Market Research published a new report, titled, "Thyristor Market by Power Rating (Below 500 MW, 500 MW-1000 MW, and Above 1000 MW), and Industry Vertical (Consumer Electronics, Telecommunication & Networking, Industrial, Automotive and Aerospace & Defense, and Healthcare): Global Opportunity Analysis and Industry Forecast, 2019–2026." The research report offers an in-depth analysis of the current market scenario, estimates, revolving aspects, and dynamic forces of the industry from 2019 to 2026
COVID-19 Impact on Smart Thermostat Market Growth 2020-2026: Share, Size, Trends …
Allied Market Research published a new report, titled, "Smart Thermostat Market by Type (WiFi, Infrared, Bluetooth, and others), Application (Split AC, Window AC, Portable ACs, and Others), and End Use (Residential, Commercial, Industrial, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026." The research report offers an in-depth analysis of the current market scenario, estimates, revolving aspects, and dynamic forces of the industry from 2019 to 2026 to identify the underlying

All 5 Releases

More Releases for EPO

Global Oenothera Biennis Oil (EPO) Market Expected to Witness a Sustainable Grow …
LP INFORMATION recently released a research report on the Oenothera Biennis Oil (EPO) market analysis, which studies the Oenothera Biennis Oil (EPO)'s industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Oenothera Biennis Oil (EPO) Market 2020-2025” Research Report categorizes the global Oenothera Biennis Oil (EPO) market by key players, product type, applications and regions,etc. The report also covers the latest
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023 According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,
Quercetin Market Global Forecast 2018 | Studied By Monteloeder, EPO S.r.l., King …
UpMarketResearch published an exclusive report on “Quercetin market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 112 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Quercetin market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa.
Global Erythropoietin (EPO) Market 2017 - Johnson & Johnson, Roche, Kyowa Hakko …
Global Erythropoietin (EPO) market Report offers decisive insights into the overall Erythropoietin (EPO) industry along with the market dimensions and evaluation for the duration 2017 to 2022. The forenamed research study covers extensive analysis of various Erythropoietin (EPO) industry segments based on the type of applications, type of product Components and services, and different geographical regions. Erythropoietin, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls
EPO Biosimilars - The Future of Erythropoietin Market
ReportsWorldwide has announced the addition of a new report title EPO Biosimilars - The Future of Erythropoietin Market to its growing collection of premium market research reports. Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered to
Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlo …
Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as involvement in the wound healing cycle